Skip to main content

Table 1 Baseline Characteristics of 181 Older Adults by Apolipoprotein E4 Genotype

From: Interactions between the apolipoprotein E4 gene and modifiable risk factors for cognitive impairment: a nationally representative panel study

Characteristic

Overall Sample

(n = 181)

APOE4 status

APOE4: no copies

(n = 136)

APOE4: ≥ 1 copy

(n = 45)

p-valuea

Age in Years, mean (SD)

77.7 (5.1)

77.9 (5.3)

77.3 (4.6)

.6701

Male Sex, n (%)

83 (45.9%)

57 (41.9%)

26 (57.8%)

.0641

Vision Impairment, n (%)

24 (13.3%)

18 (13.2%)

6 (13.3%)

.9866

Hearing loss, n (%)

25 (13.8%)

19 (14.0%)

6 (13.3%)

.9145

Elevated depressive Symptoms, n (%)

30 (16.6%)

23 (16.9%)

7 (15.6%)

.8320

More than Highschool Education

37 (20.4%)

23 (16.9%)

14 (31.1%)

.0406

Obesity (BMI ≥ 35 kg/m2), n (%)

42 (23.2%)

34 (25.0%)

8 (17.8%)

.3198

Smoking, n (%)

99 (54.7%)

73 (53.7%)

26 (57.8%)

.6319

Hypertension, n (%)

105 (58.0%)

82 (60.3%)

23 (51.1%)

.2793

Type 2 Diabetes Mellitus, n (%)

35 (19.3%)

26 (19.1%)

9 (20.0%)

.8966

  1. APOE4 Apolipoprotein E4, BMI Body Mass Index. Smoking was defined as current or past tobacco smoking
  2. ap-values are from Wilcoxon Rank-Sum Tests for continuous variables and Chi-Square Tests for categorical variables